Sushil Patel, Director at Revolution Medicines, Inc. (RVMD), sold 5,000 shares at $54.14 ($271K) on 2024-10-31, disclosed to the SEC on 2024-11-04.
Scheduled sale ($271k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| REPL | SELL | 2026-05-20 | $190K | — | Filing → |
| REPL | SELL | 2025-12-04 | $223K | — | Filing → |
| REPL | SELL | 2025-05-22 | $405K | — | Filing → |